These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21790281)

  • 1. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
    Steen VD
    Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel insights in the pathogenesis of systemic sclerosis.
    Radstake TR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):389-90. PubMed ID: 21790277
    [No Abstract]   [Full Text] [Related]  

  • 3. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 4. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancestry, ancestry-informative markers, asthma, and the quest for personalized medicine.
    Barnes KC
    J Allergy Clin Immunol; 2010 Dec; 126(6):1139-40. PubMed ID: 21134571
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted medications. New focus on companion tests.
    Reinke T
    Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies and clinical subsets: relevance to scleroderma.
    Maddison PJ
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):684-6. PubMed ID: 11020957
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcript profiling towards personalised medicine in rheumatoid arthritis.
    Verweij CL
    Neth J Med; 2009 Dec; 67(11):364-71. PubMed ID: 20009112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized medicine in rheumatology].
    Szekanecz Z
    Orv Hetil; 2013 Mar; 154(13):483-96. PubMed ID: 23524232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of pharmacogenetics in clinical practice is challenging.
    van Schie RM; de Boer A; Maitland-van der Zee AH
    Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting personal.
    Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
    [No Abstract]   [Full Text] [Related]  

  • 13. Translation towards personalized medicine in Multiple Sclerosis.
    Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
    J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personalized medicine and molecular targets of drugs].
    Nishiyama M
    Nihon Rinsho; 2010 Oct; 68(10):1917-22. PubMed ID: 20954340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of scleroderma: implications for personalized medicine?
    Assassi S; Radstake TR; Mayes MD; Martin J
    BMC Med; 2013 Jan; 11():9. PubMed ID: 23311619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human genome 10th anniversary. Waiting for the revolution.
    Marshall E
    Science; 2011 Feb; 331(6017):526-9. PubMed ID: 21292950
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding systemic sclerosis through gene expression profiling.
    Pendergrass SA; Whitfield ML; Gardner H
    Curr Opin Rheumatol; 2007 Nov; 19(6):561-7. PubMed ID: 17917536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.